The GLP is committed to full transparency. Download and review our 2019 Annual Report

Drugs for mental disorders: Why better access to services ‘will likely make things worse’

, | | October 30, 2018
pills
Image credit: Health Freedom
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

To reduce the rising burden of mental disorders around the world, the Lancet Commission on Global Mental Health and Sustainable Development has declared a need to increase psychiatric services globally, which should include an effort to “reduce the cost and improve the supply of effective psychotropic drugs for mental, neurological, and substance use disorders.”

While reducing the burden of mental disorders is certainly a laudable goal, we believe that implementing this plan will increase the global burden of mental disorders rather than decrease it.

Yet even as more and more people have been getting medical treatment for psychiatric disorders, the number of adults on government disability due to these disorders has more than tripled since 1987.

Any call for improving global mental health needs to recognize two facts: First, there are commercial forces at work in this enterprise, which urge more access to psychiatric drugs. Second, as the globalization of mental health has unfolded over the past several decades, the burden of mental disorders has increased in tandem. Without such recognition, proposals for closing the global treatment gap risks further exporting a failed paradigm of care.

Related article:  Viewpoint: Congressional proposal to loosen court ruling that blocked companies from patenting genes could 'stifle' science innovation

Indeed, it is easy to make the case, as we have sought to quickly do here, that “closing the treatment gap,” when treatment includes increased use of psychiatric drugs, will likely make things worse.

Read full, original post: Flooding the world with psychiatric drugs could boost the burden of mental disorders

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend